Vestibular schwannoma growth in patients with neurofibromatosis Type 2: A longitudinal study

Journal of Neurosurgery

Volumn 96, Issue 2, 2002, Pages 223-228

  Mautner, Victor Felix ^a   Baser, Michael E ^a   Thakkar, Sarang D ^a   Feigen, Urs M ^a   Friedman, J M ^a   Kluwe, Lan ^a  

^a NONE   (United States)

Author keywords

Natural history; Neurofibromatosis Type 2; Neurogenetics; Vestibular schwannoma

Indexed keywords

DNA; GADOLINIUM;

ACOUSTIC NEURINOMA; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CONTRAST ENHANCEMENT; FEMALE; GEL ELECTROPHORESIS; GENE MUTATION; HUMAN; LONGITUDINAL STUDY; MALE; NEURILEMOMA; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0036120061     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2002.96.2.0223     Document Type: Article

References (35)

1. Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
2. Proliferative potential of sporadic and neurofibromatosis 2-associated schwannomas as studied by MIB-1 (Ki-67) and PCNA labeling
3. Predictors of survival in neurofibromatosis 2
4. Predictors of vestibular schwannoma growth in patients with neurofibromatosis Type 2
5. Phenotypic variability in monozygotic twins with neurofibromatosis 2
6. Conservative treatment of patients with acoustic tumors
7. ERM-Merlin and EBP50 protein families in plasma membrane organization and function
8. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene
9. Severe phenotype of the neurofibromatosis type 2 in a patient with a 7.4 MB constitutional deletion on chromosome 22: Possible localization of a neurofibromatosis type 2 modifier gene?
10. Acoustic neuroma (vestibular schwannoma): Growth and surgical and nonsurgical consequences of the wait-and-see policy
11. Paediatric presentation of type 2 neurofibromatosis
12. A clinical study of type 2 neurofibromatosis
13. A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity
14. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations
15. The size of acoustic neuromas: CT and MRI
16. The neurofibromatoses: When less is more
17. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
18. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes
19. Phenotypic variability associated with 14 splice-site mutations in the NF2 gene
20. Volume growth rate of acoustic neurinomas
21. NF2 gene mutations and allelic status of 1p, 14q, and 22q in sporadic meningiomas
22. Allelic status of 1p, 14q, and 22q and NF2 gene mutations in sporadic schwannomas
23. The diagnosis and management of neurofibromatosis 2 in childhood
24. The neuroimaging and clinical spectrum of neurofibromatosis 2
25. Neurofibromatosis 2 in the pediatric age group
26. Conservative management of acoustic neuromas
27. Neurofibromatosis 2 (NF2): Clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity
28. Germ-line mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities
29. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2
30. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease
31. Vestibular (acoustic) schwannomas: Histologic features in neurofibromatosis 2 and in unilateral cases
32. The natural history of untreated acoustic neuromas
33. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
34. Differential diagnosis of type 2 neurofibromatosis: Molecular discrimination of NF2 and sporadic vestibular schwannomas